|
Jul 23, 2020
|
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
|
|
|
Jul 21, 2020
|
Dynavax Announces the Appointment of Two New Board Members
|
|
|
Jul 16, 2020
|
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
|
|
|
Jul 14, 2020
|
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant
|
|
|
Jul 08, 2020
|
Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
|
|
|
Jun 22, 2020
|
Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series
|
|
|
Jun 19, 2020
|
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant
|
|
|
Jun 09, 2020
|
Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis
|
|
|
May 28, 2020
|
Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
|
|
|
May 27, 2020
|
Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
|
